Northern Trust’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-15,124
| Closed | -$5K | – | 4355 |
|
|
2018
Q1 | $5K | Sell |
15,124
-100
| -0.7% | -$33 | ﹤0.01% | 4224 |
|
|
2017
Q4 | $25K | Buy |
15,224
+199
| +1% | +$327 | ﹤0.01% | 4141 |
|
|
2017
Q3 | $22K | Sell |
15,025
-41,535
| -73% | -$60.8K | ﹤0.01% | 4152 |
|
|
2017
Q2 | $92K | Buy |
56,560
+4,095
| +8% | +$6.66K | ﹤0.01% | 3993 |
|
|
2017
Q1 | $178K | Sell |
52,465
-36
| -0.1% | -$122 | ﹤0.01% | 3831 |
|
|
2016
Q4 | $273K | Buy |
52,501
+343
| +0.7% | +$1.78K | ﹤0.01% | 3676 |
|
|
2016
Q3 | $1.31M | Buy |
52,158
+700
| +1% | +$17.6K | ﹤0.01% | 3265 |
|
|
2016
Q2 | $1.27M | Sell |
51,458
-335
| -0.6% | -$8.28K | ﹤0.01% | 3269 |
|
|
2016
Q1 | $1.5M | Buy |
51,793
+522
| +1% | +$15.1K | ﹤0.01% | 3113 |
|
|
2015
Q4 | $1.9M | Buy |
51,271
+1,052
| +2% | +$39K | ﹤0.01% | 3090 |
|
|
2015
Q3 | $2.45M | Buy |
50,219
+41,060
| +448% | +$2M | ﹤0.01% | 2917 |
|
|
2015
Q2 | $632K | Buy |
9,159
+3,239
| +55% | +$224K | ﹤0.01% | 3500 |
|
|
2015
Q1 | $212K | Buy |
5,920
+1,416
| +31% | +$50.7K | ﹤0.01% | 3851 |
|
|
2014
Q4 | $57K | Hold |
4,504
| – | – | ﹤0.01% | 4077 |
|
|
2014
Q3 | $69K | Sell |
4,504
-12
| -0.3% | -$184 | ﹤0.01% | 4096 |
|
|
2014
Q2 | $122K | Sell |
4,516
-114
| -2% | -$3.08K | ﹤0.01% | 3974 |
|
|
2014
Q1 | $124K | Buy |
4,630
+1,019
| +28% | +$27.3K | ﹤0.01% | 3896 |
|
|
2013
Q4 | $89K | Buy |
3,611
+1,820
| +102% | +$44.9K | ﹤0.01% | 3886 |
|
|
2013
Q3 | $58K | Buy |
1,791
+149
| +9% | +$4.83K | ﹤0.01% | 3917 |
|
|
2013
Q2 | $49K | Buy |
+1,642
| New | +$49K | ﹤0.01% | 3930 |
|